Even though low cost playing cards may also help relieve the burden of high drug expenditures inside the short term, they do not tackle the systemic issues driving up prescription price ranges within the U.S. Broader plan changes could deal with the foundation triggers of mounting drug price ranges, such as deficiency of transparency in pricing and